| 前收市價 | 12.80 |
| 開市 | 12.80 |
| 買盤 | 13.85 |
| 賣出價 | 15.60 |
| 拍板 | 135.00 |
| 到期日 | 2025-12-19 |
| 今日波幅 | 12.80 - 12.80 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 182 |
Insider Monkey20 Fastest Growing Health Tech Companies in the World
In this article, we will be taking a look at the 20 fastest growing health tech companies in the world. If you do not want to learn about the trends in digital health market, head straight to the 5 Fastest Growing Health tech Companies in the World. Explosive Growth and Key Trends in the Digital […]
Investing.com HK美股開市前：三大股指期貨跳水 道指期貨大跌400點 GDP現不祥之兆
Investing.com - 周四(25日)開市前，美國股指期貨大跌，道指、納指、標普500、小盤股指數期貨皆跌逾1%，此前美國公佈的第一季度GDP數據釋放利空。一方面，美國第一季度GDP增速從3.9%超預期將至1.6%，預期是2.5%。另一方面，通脹指標之一的美國第一季度GDP平減指數從1.7%升至3.1%，高於預期的3.0%。
- Reuters
UPDATE 3-Merck raises 2024 profit forecast on surging sales of cancer drug Keytruda
Merck & Co on Thursday raised its annual profit and revenue forecasts on the back of double-digit growth for its blockbuster cancer drug Keytruda, the world's top selling prescription medicine. Merck forecast 2024 sales between $63.1 billion and $64.3 billion, up from its previous view of $62.7 billion to $64.2 billion. Analysts are estimating sales of $63.83 billion.
